An HPLC-peroxyoxalate chemiluminescence (PO-CL) method for simultaneous determination of methylphenidate (MPH) and ritalinic acid (RA) was developed.Furthermore, the proposed method was applied to monitor MPH and RA after an administration of MPH to rat. The deproteinized plasma spiked with 1-(3-trifluoromethylphenyl)piperazine (IS) was dried up and labeled with 4-(N,N-dimethylaminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole (DBD-F). The labeled sample was cleaned-up with two kinds of solid-phase extraction cartridges, and the DBD-labels were separated on an ODS column with gradient elution using a mixture of CH 3 CN and imidazole-HNO 3 buffer. The separation of MPH and RA can be achieved within 33 min. The LODs of MPH and RA at signal-to-noise ratio of 3 were 2.2 and 0.4 ng/mL, respectively. Moreover, monitoring of MPH and RA after MPH administration (10 mg/kg) to rat could be performed. The concentration of RA at 480 min after administration was 8 times higher than that of MPH.The proposed HPLC-PO-CL method was useful for determination of MPH and RA in rat plasma and was successfully applied to monitor these substances after MPH administration. (172 words)